EANM 2025 Annual Congress
October 4-8, 2025 | Barcelona, Spain
Join us at EANM 2025, the annual congress of the European Association of Nuclear Medicine that explores the latest breakthroughs across all nuclear medicine fields.
The development of radiopharmaceutical solutions, whether for diagnostics or therapeutics, is full of challenges. Companies must navigate diverse regulatory landscapes, a complex payer environment with high prices and cost pressures, and varying levels of nuclear medicine maturity across geographies.
Meet our team at EANM 2025 and learn how we can accompany you on this complex development journey. We understand each step; from choosing the relevant regulatory pathway to delineating the reimbursement landscape and determining optimal clinical and competitive positioning of your product.
Our Latest Nuclear Medicine Insights
White Paper
This white paper breaks down the full supply chain—from isotope production to patient delivery—and uncovers the pressure points impacting growth.
Download now
Case study
Discover a success story of a client that was conducting a Phase III trial designed to support registration and launch of a radiopharmaceutical therapy in the United States for prostate cancer.
White Paper
This white paper offers an in-depth review of the evolving PET radiotracers landscape, changes in the accessibility of the predominant isotopes, and emerging commercial dynamics shaping the field.
Subscribe to our newsletter for the latest news, events, and thought leadership